[Percutaneous mitral commissurotomy and left ventricular function in severe mitral stenosis]

Rachid Mechmèche1, Ali Chérif, Abdeljelil Farhati

  • 1Service des Explorations Fonctionnelles Cardiologiques, Hôpital la Rabta, Tunis.

Insights

Percutaneous mitral commissurotomy (PMC) significantly improves left ventricular (LV) performance. The procedure increases LV filling, leading to greater end-diastolic volume and stroke volume after relieving mitral stenosis.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Severe mitral stenosis obstructs blood flow, impacting left ventricular (LV) function.
  • Percutaneous mitral commissurotomy (PMC) is a key intervention for managing mitral stenosis.
  • Understanding the immediate hemodynamic effects of PMC on LV performance is crucial.

Purpose of the Study:

  • To evaluate the acute impact of percutaneous mitral commissurotomy (PMC) on left ventricular (LV) performance.
  • To assess changes in LV end-diastolic volume and stroke volume post-PMC.

Main Methods:

  • Cardiac catheterization and angiography were performed before and 5 minutes after successful PMC.
  • Thirty patients with severe mitral stenosis in sinus rhythm and without hypertension or coronary artery disease were studied.

Main Results:

  • A significant increase in left ventricular end-diastolic volume was observed immediately after PMC.
  • Stroke volume also demonstrated a significant increase post-procedure.
  • These improvements are attributed to enhanced LV filling following the relief of mitral mechanical obstruction.

Conclusions:

  • PMC rapidly improves LV performance by increasing LV filling and stroke volume.
  • Relieving mitral obstruction via PMC has a beneficial immediate effect on cardiac hemodynamics.
  • The study highlights the positive acute hemodynamic consequences of successful PMC in severe mitral stenosis.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...